Literature DB >> 18347319

Metabotropic glutamate receptors: synaptic modulators and therapeutic targets for neurologic disease.

Eduardo E Benarroch1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347319     DOI: 10.1212/01.wnl.0000306315.03021.2a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  28 in total

Review 1.  Neurotransmitter-mediated control of neurogenesis in the adult vertebrate brain.

Authors:  Daniel A Berg; Laure Belnoue; Hongjun Song; András Simon
Journal:  Development       Date:  2013-06       Impact factor: 6.868

2.  Enhanced sensitivity to attenuation of conditioned reinstatement by the mGluR 2/3 agonist LY379268 and increased functional activity of mGluR 2/3 in rats with a history of ethanol dependence.

Authors:  Peter R Kufahl; Rémi Martin-Fardon; Friedbert Weiss
Journal:  Neuropsychopharmacology       Date:  2011-08-31       Impact factor: 7.853

3.  Test-retest reproducibility of the metabotropic glutamate receptor 5 ligand [¹⁸F]FPEB with bolus plus constant infusion in humans.

Authors:  Eunkyung Park; Jenna M Sullivan; Beata Planeta; Jean-Dominique Gallezot; Keunpoong Lim; Shu-Fei Lin; Jim Ropchan; Timothy J McCarthy; Yu-Shin Ding; Evan D Morris; Wendol A Williams; Yiyun Huang; Richard E Carson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-06-05       Impact factor: 9.236

4.  Role of Paraventricular Nucleus Glutamate Signaling in Regulation of HPA Axis Stress Responses.

Authors:  Nathan K Evanson; James P Herman
Journal:  Interdiscip Inf Sci       Date:  2015-09-13

5.  Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET.

Authors:  Jonathan M DuBois; Olivier G Rousset; Jared Rowley; Manuel Porras-Betancourt; Andrew J Reader; Aurelie Labbe; Gassan Massarweh; Jean-Paul Soucy; Pedro Rosa-Neto; Eliane Kobayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-21       Impact factor: 9.236

6.  Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5).

Authors:  Laura T Haas; Mikhail A Kostylev; Stephen M Strittmatter
Journal:  J Biol Chem       Date:  2014-08-22       Impact factor: 5.157

7.  Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5.

Authors:  Marianne Renner; Pascale N Lacor; Pauline T Velasco; Jian Xu; Anis Contractor; William L Klein; Antoine Triller
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

Review 8.  The role of glutamate in neuronal ischemic injury: the role of spark in fire.

Authors:  Botros B Kostandy
Journal:  Neurol Sci       Date:  2011-11-02       Impact factor: 3.307

9.  SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients.

Authors:  Sierk Haenisch; Yi Zhao; Aparna Chhibber; Kitti Kaiboriboon; Lynn V Do; Silke Vogelgesang; Nicholas M Barbaro; Brian K Alldredge; Daniel H Lowenstein; Ingolf Cascorbi; Deanna L Kroetz
Journal:  Neurobiol Dis       Date:  2015-03-10       Impact factor: 5.996

10.  Mutant β-III spectrin causes mGluR1α mislocalization and functional deficits in a mouse model of spinocerebellar ataxia type 5.

Authors:  Karen R Armbrust; Xinming Wang; Tyisha J Hathorn; Samuel W Cramer; Gang Chen; Tao Zu; Takashi Kangas; Anastasia N Zink; Gülin Öz; Timothy J Ebner; Laura P W Ranum
Journal:  J Neurosci       Date:  2014-07-23       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.